Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications (Q36516174)

14 August 2017

1 reference

title

Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications (English)

1 reference

14 August 2017

Tsagarakis S

1

1 reference

PubMed ID

16794373

14 August 2017

Vassiliadi D

series ordinal

2

1 reference

PubMed ID

16794373

14 August 2017

Thalassinos N

series ordinal

3

1 reference

14 August 2017

1 May 2006

1 reference

Journal of Endocrinological Investigation

14 August 2017

1 reference

14 August 2017

29

1 reference

14 August 2017

5

1 reference

14 August 2017

471-482

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03344133

14 August 2017

0 references

cites work

Management of the clinically inapparent adrenal mass ("incidentaloma")

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Preclinical Cushing disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Occult Cushing's syndrome in type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Abnormalities of endocrine function in patients with clinically "silent" adrenal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Incidentalomas. A disease of modern technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Preclinical Cushing's syndrome: report of seven cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Cushing's syndrome: A review of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Autonomy of cortisol secretion in clinically silent adrenal incidentaloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Subclinical Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Subclinical hormone secretion by incidentally discovered adrenal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Evaluation of hormonal function in a series of incidentally discovered adrenal masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Adrenal incidentaloma: report of 33 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Prevalence and natural history of adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Long-term follow-up study of patients with adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

The assessment of glucocorticoid replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Cardiovascular disease and risk factors in adults with hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Mortality and hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Prevalence of Subclinical Cushing's Syndrome in 70 Patients with Adrenal Incidentaloma: Clinical, Biochemical and Surgical Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Diurnal changes in glucocorticoid sensitivity in human peripheral blood samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Subclinical Cushing's syndrome in adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344133

Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates

21 January 2018

1 reference

12 December 2020

Incidentally discovered adrenal tumors: an institutional perspective

1 reference

12 December 2020

Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?

1 reference

12 December 2020

Can adrenal incidentalomas be safely observed?

1 reference

12 December 2020

A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome

1 reference

12 December 2020

Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism.

1 reference

12 December 2020

Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals.

1 reference

12 December 2020

Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome

1 reference

12 December 2020

Scintigraphic diagnosis of subclinical Cushing's syndrome in patients with adrenal incidentalomas

1 reference

12 December 2020

Development of overt Cushing's syndrome in patients with adrenal incidentaloma

1 reference

12 December 2020

Partially autonomous cortisol secretion by incidentally discovered adrenal adenomas

1 reference

12 December 2020

Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features

1 reference

12 December 2020

Bone loss rate in adrenal incidentalomas: a longitudinal study.

1 reference

12 December 2020

Subclinical Cushing's disease accompanied by malignant hypertension and diabetes mellitus.

1 reference

12 December 2020

Management of incidentally discovered adrenal masses and risk of malignancy

1 reference

12 December 2020

Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management

1 reference

12 December 2020

Imaging functional nodules of the adrenal glands with 131-I-19-iodocholesterol

1 reference

12 December 2020

Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome

1 reference

12 December 2020

Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas)

1 reference

12 December 2020

Functional and scintigraphic evaluation of the silent adrenal mass

1 reference

12 December 2020

The diagnosis and differential diagnosis of Cushing's syndrome

1 reference

12 December 2020

A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

1 reference

12 December 2020

A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states.

1 reference

12 December 2020

Tissue specificity of glucocorticoid sensitivity in healthy adults

1 reference

12 December 2020

Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients

1 reference

12 December 2020

Subclinical Cushing's syndrome in adrenal incidentaloma

1 reference

12 December 2020

Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism

1 reference

12 December 2020

Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist?

1 reference

12 December 2020

Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis

1 reference

12 December 2020

The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis

1 reference

12 December 2020

Glucocorticoid replacement therapy: are patients over treated and does it matter?

1 reference

12 December 2020

Different patterns of steroid secretion in patients with adrenal incidentaloma

1 reference

12 December 2020

Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma

1 reference

12 December 2020

Adrenal incidentalomas and glucocorticoid autonomy

1 reference

12 December 2020

Glucocortidoid sensitivity assessed in peripheral blood cells do not correlate with the feedback sensitivity of the hypothalamo-pituitary adrenal AXIS

1 reference

12 December 2020

Adrenal incidentaloma: a new cause of the metabolic syndrome?

1 reference

12 December 2020

Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone

1 reference

12 December 2020

Preclinical Cushing's syndrome in patients with an adrenal incidentaloma

1 reference

12 December 2020

Risk factors and long-term follow-up of adrenal incidentalomas

1 reference

12 December 2020

Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients

1 reference

12 December 2020

Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03344133

1 reference

14 August 2017

1 reference

PubMed ID

16794373